Vivani Medical, Inc. (NASDAQ:VANI) Shares Purchased by Wealthedge Investment Advisors LLC

Wealthedge Investment Advisors LLC increased its stake in shares of Vivani Medical, Inc. (NASDAQ:VANI) by 238.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 125,033 shares of the company’s stock after purchasing an additional 88,132 shares during the quarter. Wealthedge Investment Advisors LLC owned 0.21% of Vivani Medical worth $131,000 at the end of the most recent quarter.

Separately, Jane Street Group LLC acquired a new position in Vivani Medical during the 4th quarter worth $66,000. Institutional investors own 6.78% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “buy” rating and set a $4.00 target price on shares of Vivani Medical in a research note on Monday, May 19th.

Vivani Medical Stock Performance

NASDAQ:VANI opened at $1.25 on Friday. The stock has a 50-day simple moving average of $1.34 and a 200-day simple moving average of $1.18. The stock has a market cap of $74.05 million, a P/E ratio of -2.78 and a beta of 2.99. Vivani Medical, Inc. has a 1 year low of $0.91 and a 1 year high of $1.80.

Vivani Medical (NASDAQ:VANI) last released its quarterly earnings data on Wednesday, August 13th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.02). On average, equities research analysts predict that Vivani Medical, Inc. will post -0.41 EPS for the current year.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.